AAAAAA

   
Results: 1-11 |
Results: 11
IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer
Authors: Herbst, RS Kim, ES Harari, PM
Citation: Rs. Herbst et al., IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer, EXPERT OP B, 1(4), 2001, pp. 719-732
Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling
Authors: Harari, PM Huang, SM
Citation: Pm. Harari et Sm. Huang, Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling, SEM RAD ONC, 11(4), 2001, pp. 281-289
Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation
Authors: Harari, PM Huang, SM
Citation: Pm. Harari et Sm. Huang, Head and neck cancer as a clinical model for molecular targeting of therapy: Combining EGFR blockade with radiation, INT J RAD O, 49(2), 2001, pp. 427-433
Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cyclekinetics, and tumor angiogenesis
Authors: Huang, SM Harari, PM
Citation: Sm. Huang et Pm. Harari, Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cyclekinetics, and tumor angiogenesis, CLIN CANC R, 6(6), 2000, pp. 2166-2174
Modulation of molecular targets to enhance radiation
Authors: Harari, PM Huang, SM
Citation: Pm. Harari et Sm. Huang, Modulation of molecular targets to enhance radiation, CLIN CANC R, 6(2), 2000, pp. 323-325
Confirmation of improved local-regional control with altered fractionationin head and neck cancer
Authors: Fowler, JF Harari, PM
Citation: Jf. Fowler et Pm. Harari, Confirmation of improved local-regional control with altered fractionationin head and neck cancer, INT J RAD O, 48(1), 2000, pp. 3-6
Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results
Authors: Huang, SM Harari, PM
Citation: Sm. Huang et Pm. Harari, Epidermal growth factor receptor inhibition in cancer therapy: Biology, rationale and preliminary clinical results, INV NEW DR, 17(3), 1999, pp. 259-269
Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas
Authors: Bock, JM Pickart, MA Pink, JJ Harari, PM
Citation: Jm. Bock et al., Modulation of tumor cell proliferation and apoptosis by polyamine depletion in cells of head and neck squamous cell carcinomas, RADIAT RES, 152(6), 1999, pp. 604-610
Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck
Authors: Huang, SM Bock, JM Harari, PM
Citation: Sm. Huang et al., Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck, CANCER RES, 59(8), 1999, pp. 1935-1940
Influence of computed tomography on pretherapeutic tumor staging in head and neck cancer patients
Authors: Prehn, RB Pasic, TR Harari, PM Brown, WD Ford, CN
Citation: Rb. Prehn et al., Influence of computed tomography on pretherapeutic tumor staging in head and neck cancer patients, OTO H N SUR, 119(6), 1998, pp. 628-633
Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation
Authors: Harari, PM Sharda, NN Brock, LK Paliwal, BR
Citation: Pm. Harari et al., Improving dose homogeneity in routine head and neck radiotherapy with custom 3-D compensation, RADIOTH ONC, 49(1), 1998, pp. 67-71
Risultati: 1-11 |